COCRYSTAL PHARMA, INC. Increase Decrease In Operating Lease Liability
COCRYSTAL PHARMA, INC. (COCP) reported Increase Decrease In Operating Lease Liability of -$164.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-13
- COCRYSTAL PHARMA, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$83.00K.
- COCRYSTAL PHARMA, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$81.00K.
- COCRYSTAL PHARMA, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$75.00K.
- COCRYSTAL PHARMA, INC. increase decrease in operating lease liability for the quarter ending 2025-06-30 was -$75.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month |
|---|---|---|---|
| 2026-06-30 | -$83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$164.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$81.00K 10-Q · filed 2026-05-15 | ||
| 2025-09-30 | -$75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$150.00K derived: sum of 2 quarters · filed 2026-08-13 | -$223.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | -$75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$148.00K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | -$73.00K 10-Q · filed 2026-05-15 | ||
| 2024-09-30 | -$69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$111.00K derived: sum of 2 quarters · filed 2025-11-14 | -$142.00K 10-Q · filed 2025-11-14 |
| 2024-06-30 | -$42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$73.00K 10-Q · filed 2025-08-14 | |
| 2024-03-31 | -$31.00K 10-Q · filed 2025-05-15 | ||
| 2023-06-30 | -$59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$115.00K 10-Q · filed 2024-08-14 | |
| 2023-03-31 | -$56.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |